Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Mariottini

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis and Related Disorders|June 24, 2017
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reportsBenedetta Forci, Alice Mariottini, Claudia Mechi, et al.
Frontiers in Neurology|March 15, 2024
Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case reportAlice Mariottini, Alessandro Barilaro, Antonio Lotti, et al.
Current Neurology and Neuroscience Reports|August 17, 2023
Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent AdvancesAlice Mariottini, Eleonora De Matteis, Maria Teresa Cencioni, et al.
Bioengineering (Basel, Switzerland)|February 25, 2023
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An UpdateAlice Mariottini, Giovanni Bulgarini, Sara Cornacchini, et al.
International Journal of Molecular Sciences|July 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced DepletionAnna Chiara Mazzeo, Laura Calabresi, Valentina Damato, et al.
Frontiers in Neurology|August 28, 2023
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic managementAntonio Lotti, Alessandro Barilaro, Alice Mariottini, et al.
Multiple Sclerosis and Related Disorders|November 3, 2020
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosisMatteo Pasca, Benedetta Forci, Alice Mariottini, et al.
Journal of Neurology|March 3, 2022
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosisAlice Mariottini, Andrea Bertozzi, Leonardo Marchi, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residentsAlice Mariottini, Benedetta Forci, Elisa Gualdani, et al.
Journal of the American Chemical Society|April 22, 2026
Phenotype Classification of Intact Cells by NMR Spectroscopy through Machine Learning ApproachesCarlo Mengucci, Claudia Dell'Amico, Simona Del Giudice, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis and Related Disorders|June 24, 2017
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reportsBenedetta Forci, Alice Mariottini, Claudia Mechi, et al.
Frontiers in Neurology|March 15, 2024
Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case reportAlice Mariottini, Alessandro Barilaro, Antonio Lotti, et al.
Current Neurology and Neuroscience Reports|August 17, 2023
Haematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis: Recent AdvancesAlice Mariottini, Eleonora De Matteis, Maria Teresa Cencioni, et al.
Bioengineering (Basel, Switzerland)|February 25, 2023
Hematopoietic Stem Cell Transplantation for the Treatment of Autoimmune Neurological Diseases: An UpdateAlice Mariottini, Giovanni Bulgarini, Sara Cornacchini, et al.
International Journal of Molecular Sciences|July 29, 2025
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced DepletionAnna Chiara Mazzeo, Laura Calabresi, Valentina Damato, et al.
Frontiers in Neurology|August 28, 2023
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic managementAntonio Lotti, Alessandro Barilaro, Alice Mariottini, et al.
Multiple Sclerosis and Related Disorders|November 3, 2020
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosisMatteo Pasca, Benedetta Forci, Alice Mariottini, et al.
Journal of Neurology|March 3, 2022
Effect of disease-modifying treatments on antibody-mediated response to anti-COVID19 vaccination in people with multiple sclerosisAlice Mariottini, Andrea Bertozzi, Leonardo Marchi, et al.
Multiple Sclerosis and Related Disorders|February 26, 2022
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residentsAlice Mariottini, Benedetta Forci, Elisa Gualdani, et al.
Journal of the American Chemical Society|April 22, 2026
Phenotype Classification of Intact Cells by NMR Spectroscopy through Machine Learning ApproachesCarlo Mengucci, Claudia Dell'Amico, Simona Del Giudice, et al.
Pageof 5